PortfoliosLab logoPortfoliosLab logo
Bausch + Lomb Corp (BLCO)
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN
CA0717051076
IPO Date
May 6, 2022

Highlights

Market Cap
$5.63B
Enterprise Value
$5.32B
EPS (TTM)
-$1.02
Total Revenue (TTM)
$5.08B
Gross Profit (TTM)
$5.08B
EBITDA (TTM)
$113.00M
Year Range
$10.45 - $18.92
Target Price
$18.60
ROA (TTM)
-2.57%
ROE (TTM)
-5.58%

Share Price Chart


Loading graphics...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Bausch + Lomb Corp

Often compared with BLCO:
BLCO vs. SPYBLCO vs. TEM

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Bausch + Lomb Corp, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


Loading graphics...

S&P 500 Index

Returns By Period

Bausch + Lomb Corp (BLCO) has returned -6.91% so far this year and 9.66% over the past 12 months.


Bausch + Lomb Corp

1D
4.19%
1M
-13.11%
YTD
-6.91%
6M
5.51%
1Y
9.66%
3Y*
-2.98%
5Y*
10Y*

Benchmark (S&P 500 Index)

1D
2.91%
1M
-5.09%
YTD
-4.63%
6M
-2.39%
1Y
16.33%
3Y*
16.69%
5Y*
10.18%
10Y*
12.16%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Monthly Returns

Based on dividend-adjusted daily data since May 6, 2022, BLCO's average daily return is +0.01%, while the average monthly return is -0.06%.

Historically, 49% of months were positive and 51% were negative. The best month was Jul 2024 with a return of +18.6%, while the worst month was Apr 2025 at -20.3%. The longest winning streak lasted 4 consecutive months, and the longest losing streak was 7 months.

On a daily basis, BLCO closed higher 49% of trading days. The best single day was Sep 16, 2024 with a return of +14.5%, while the worst single day was Apr 30, 2025 at -15.7%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2026-2.22%9.58%-13.11%-6.91%
2025-3.93%-7.78%-9.38%-20.28%-0.78%13.43%4.77%7.34%3.01%-0.86%8.37%5.50%-5.43%
2024-17.88%17.77%4.85%-15.95%5.50%-5.35%18.60%-4.59%17.41%5.13%-2.27%-8.88%5.86%
202311.15%1.16%-0.17%0.29%2.29%12.37%-1.00%-9.76%-5.47%-4.78%-4.52%10.71%9.99%
2022-14.95%-10.41%-5.58%3.41%3.09%-7.04%6.10%2.51%-22.45%

Benchmark Metrics

Bausch + Lomb Corp has an annualized alpha of -11.62%, beta of 1.10, and R² of 0.21 versus S&P 500 Index. Calculated based on daily prices since May 09, 2022.

  • This stock participated in 124.64% of S&P 500 Index downside but only 50.44% of its upside — more exposed to losses than it benefited from rallies.
  • R² of 0.21 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
-11.62%
Beta
1.10
0.21
Upside Capture
50.44%
Downside Capture
124.64%

Return for Risk

Risk / Return Rank

BLCO ranks 49 for risk / return — on par with similar stocks. You're getting a typical balance of risk and reward. Not a standout, but not a red flag either — a reasonable choice if other factors align with your goals.


BLCO Risk / Return Rank: 4949
Overall Rank
BLCO Sharpe Ratio Rank: 4848
Sharpe Ratio Rank
BLCO Sortino Ratio Rank: 4444
Sortino Ratio Rank
BLCO Omega Ratio Rank: 4545
Omega Ratio Rank
BLCO Calmar Ratio Rank: 5353
Calmar Ratio Rank
BLCO Martin Ratio Rank: 5454
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for Bausch + Lomb Corp (BLCO) and compare them to a chosen benchmark (S&P 500 Index).


BLCOBenchmarkDifference

Sharpe ratio

Return per unit of total volatility

0.22

0.90

-0.67

Sortino ratio

Return per unit of downside risk

0.60

1.39

-0.78

Omega ratio

Gain probability vs. loss probability

1.08

1.21

-0.13

Calmar ratio

Return relative to maximum drawdown

0.50

1.40

-0.89

Martin ratio

Return relative to average drawdown

1.25

6.61

-5.35

Explore BLCO risk-adjusted metrics in detail

Dive deeper into individual metrics with historical trends, benchmark comparisons, and performance across different time periods.

Dividends

Dividend History


Bausch + Lomb Corp doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading graphics...

Worst Drawdowns

The table below displays the maximum drawdowns of the Bausch + Lomb Corp. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Bausch + Lomb Corp was 48.07%, occurring on May 6, 2025. The portfolio has not yet recovered.

The current Bausch + Lomb Corp drawdown is 24.25%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-48.07%Jul 14, 2023455May 6, 2025
-33.2%May 9, 202225Jun 13, 2022263Jun 30, 2023288
-3.83%Jul 5, 20235Jul 11, 20232Jul 13, 20237

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading graphics...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Bausch + Lomb Corp over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Bausch + Lomb Corp is priced in the market compared to other companies in the Medical Instruments & Supplies industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for BLCO relative to other companies in the Medical Instruments & Supplies industry. Currently, BLCO has a P/S ratio of 1.1. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for BLCO in comparison with other companies in the Medical Instruments & Supplies industry. Currently, BLCO has a P/B value of 0.9. This P/B ratio is low compared to industry peers. It might indicate the stock is undervalued or that the company’s assets are not expected to generate strong returns.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items